Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.
Mascarenhas J, Migliaccio AR, Kosiorek H, Bhave R, Palmer J, Kuykendall A, Mesa R, Rampal RK, Gerds AT, Yacoub A, Pettit K, Talpaz M, Komrokji R, Kremyanskaya M, Gonzalez A, Fabris F, Johnson K, Dougherty M, McGovern E, Arango Ossa J, Domenico D, Farnoud N, Weinberg RS, Kong A, Najfeld V, Vannucchi AM, Arciprete F, Zingariello M, Falchi M, Salama ME, Mead-Harvey C, Dueck A, Varricchio L, Hoffman R. Mascarenhas J, et al. Among authors: dougherty m. Clin Cancer Res. 2023 Sep 15;29(18):3622-3632. doi: 10.1158/1078-0432.CCR-23-0276. Clin Cancer Res. 2023. PMID: 37439808 Free PMC article. Clinical Trial.
Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.
Feld J, Tremblay D, Dougherty M, Czaplinska T, Sanchez G, Brady C, Kremyanskaya M, Bar-Natan M, Keyzner A, Marcellino BK, Gabrilove J, Navada SC, Silverman LR, El Jamal SM, Mascarenhas J, Shih AH. Feld J, et al. Among authors: dougherty m. Hemasphere. 2021 Mar 9;5(4):e549. doi: 10.1097/HS9.0000000000000549. eCollection 2021 Apr. Hemasphere. 2021. PMID: 33718803 Free PMC article.
PD-1 inhibition in advanced myeloproliferative neoplasms.
Hobbs G, Cimen Bozkus C, Moshier E, Dougherty M, Bar-Natan M, Sandy L, Johnson K, Foster JE, Som T, Macrae M, Marble H, Salama M, El Jamal SM, Zubizarreta N, Wadleigh M, Stone R, Bhardwaj N, Iancu-Rubin C, Mascarenhas J. Hobbs G, et al. Among authors: dougherty m. Blood Adv. 2021 Dec 14;5(23):5086-5097. doi: 10.1182/bloodadvances.2021005491. Blood Adv. 2021. PMID: 34581778 Free PMC article.
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor.
Tremblay D, Dougherty M, Mascarenhas J, Gallagher EJ. Tremblay D, et al. Among authors: dougherty m. Front Endocrinol (Lausanne). 2023 Jun 29;14:1141029. doi: 10.3389/fendo.2023.1141029. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455900 Free PMC article. Review.
Catalyzing communities of research rigour champions.
Brumback AC, Ngiam WXQ, Lapato DM, Allison DB, Daniels CL, Dougherty M, Hazlett HF, Kerr KL, Pusek S, Schrag N; NINDS workshop Catalyzing Communities of Research Rigor Champions. Brumback AC, et al. Among authors: dougherty m. Brain Commun. 2024 Apr 9;6(3):fcae120. doi: 10.1093/braincomms/fcae120. eCollection 2024. Brain Commun. 2024. PMID: 38764774 Free PMC article.
Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes.
Barlowe TS, Anderson C, Sandler RS, Subramaniam D, Muratore A, Buse JB, Gouker LN, Majithia RT, Shaheen NJ, Stürmer T, Dougherty MK. Barlowe TS, et al. Among authors: dougherty mk. Clin Gastroenterol Hepatol. 2024 May 15:S1542-3565(24)00453-1. doi: 10.1016/j.cgh.2024.04.038. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38759826
725 results